3644 results for «2755»

Filter By

3644 results

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

22 May 2025 – From EuroPCR 2025

This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.

Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.

The venous case presentation...

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

Symplicity Spyral renal denervation: more insights from clinical practice

21 May 2025 – From EuroPCR 2025

Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...

Symplicity Spyral renal denervation: more insights from clinical practice

A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients

22 May 2025 – From EuroPCR 2025

This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...

A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients

Challenging scenarios in patient with multivessel disease

20 May 2025 – From EuroPCR 2025

Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.

Challenging scenarios in patient with multivessel disease

A simple low profile solution to the pulmonary embolism problem: EKOS

21 May 2025 – From EuroPCR 2025

Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...

A simple low profile solution to the pulmonary embolism problem: EKOS

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

21 May 2025 – From EuroPCR 2025

Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

Advanced imaging in structural heart disease interventions

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.

You'll also discover how AI-enabled device detection technology is being integrated into...

Advanced imaging in structural heart disease interventions

Advancing renal denervation in China: from guidelines to practice

20 May 2025 – From EuroPCR 2025

Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...

Advancing renal denervation in China: from guidelines to practice

Tailoring transcatheter mitral therapies: a new era

20 May 2025 – From EuroPCR 2025

This session focuses on the evolving landscape of transcatheter mitral valve therapies. Learn about strategic programme development, patient phenotyping to guide device selection and repair versus replacement decisions, and the latest innovations and approvals in transcatheter mitral valve replacement.

Tailoring transcatheter mitral therapies: a new era

Advancing the standard of care in PCI with Bioadaptor: from simple to complex

21 May 2025 – From EuroPCR 2025

This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...

Advancing the standard of care in PCI with Bioadaptor: from simple to complex

Managing complex STEMI patients in diverse healthcare systems - Adapting best practices to local realities

20 May 2025 – From EuroPCR 2025

Addressing the complexities of STEMI management across diverse healthcare systems, this session highlights challenges and adaptive strategies tailored to geographic and resource-specific realities. Learn from regional experts on thrombus burden, late presentations, cardiogenic shock, and multivessel disease management.

Managing complex STEMI patients in diverse healthcare systems - Adapting best practices to local realities

Align for the future with the Myval Octapro transcatheter heart valve series

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.

Clinical insights are backed by key data...

Align for the future with the Myval Octapro transcatheter heart valve series

Personalised Vascular Care Award - Competition

20 May 2025 – From EuroPCR 2025

Celebrate innovation in personalised vascular care through this award competition session. Presentations cover topics including coronary revascularisation decision-making, INOCA prevalence, endothelial shear stress, bifurcation stenting predictors, CT plaque analysis, and early STEMI discharge protocols.

Personalised Vascular Care Award - Competition

Broadening OPTIONs for LAA closure: innovations and outcomes

20 May 2025 – From EuroPCR 2025

Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...

Broadening OPTIONs for LAA closure: innovations and outcomes

Which techniques for the treatment of left main lesions ?

20 May 2025 – From EuroPCR 2025

This session reviews advanced techniques for treating left main coronary artery lesions. Learn about precise stent positioning, T-modified bifurcation techniques, CHIP PCI approaches, proximal optimisation, and the innovative RODIN-CUT technique to optimize procedural success.

Which techniques for the treatment of left main lesions ?

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a comprehensive update on cardiogenic shock and high-risk PCI, featuring expert analysis of the DanGer-SHOCK and ECLS-SHOCK trials, new insights one year after DanGer-SHOCK, and practical considerations for managing PCI in patients with severely reduced LVEF. Expect to gain a deeper...

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

Impact of transcatheter mitral valve treatment on ventricular dimensions and functions

20 May 2025 – From EuroPCR 2025

Investigate the impact of transcatheter mitral valve therapies on ventricular dimensions and function. This session discusses invasive physiology changes, left and right ventricular remodeling post-TEER and TMVR, and geometric alterations of the mitral annulus, presenting data from multiple registries and studies.

Impact of transcatheter mitral valve treatment on ventricular dimensions and functions

Challenges and solutions in an expanding TAVI world

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session addresses key challenges and emerging solutions in today’s rapidly evolving TAVI landscape. It presents the latest evidence on valve replacement in low-risk patients with aortic stenosis, alongside strategies for navigating the complexities of lifetime management in TAVI candidates. The programme features a...

Challenges and solutions in an expanding TAVI world
Didn’t find what you were looking for?